Association of adiponectin with mortality in older adults: The Health, Aging, and Body Composition Study

J. Poehls, C. L. Wassel, T. B. Harris, Peter J Havel, M. M. Swarbrick, S. R. Cummings, A. B. Newman, S. Satterfield, A. M. Kanaya

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Aims/hypothesis: Despite inverse associations with insulin resistance and adiposity, adiponectin has been associated with both increased and decreased risk of cardiovascular disease. We examined whether adiponectin is associated with total and cardiovascular mortality in older adults with well-characterised body composition. Methods: We analysed data from 3,075 well-functioning adults aged 69-79 years at baseline. Mortality data were obtained over 6.6∈±∈1.6 years. We used Cox proportional hazards models adjusting for covariates in stages to examine the association between adiponectin and total and cardiovascular mortality. Results: There were 679 deaths, 36% of which were from cardiovascular disease. Unadjusted levels of adiponectin were not associated with total or cardiovascular mortality. However, after adjusting for sex and race, adiponectin was associated with an increased risk of both total mortality (hazard ratio 1.26, 95% CI 1.15-1.37, per SD) and cardiovascular mortality (hazard ratio 1.35, 95% CI 1.17-1.56, per SD). Further adjustment for study site, smoking, hypertension, diabetes, prevalent heart disease, HDL-cholesterol, LDL-cholesterol, renal function, fasting insulin, triacylglycerol, BMI, visceral fat, thigh intermuscular fat and thigh muscle area did not attenuate this association. This association between adiponectin and increased mortality risk did not vary by sex, race, body composition, diabetes, prevalent cardiovascular disease, smoking or weight loss. Conclusions/interpretation: Higher levels of adiponectin were associated with increased risks of total and cardiovascular mortality in this study of older persons.

Original languageEnglish (US)
Pages (from-to)591-595
Number of pages5
JournalDiabetologia
Volume52
Issue number4
DOIs
StatePublished - Apr 2009

Fingerprint

Adiponectin
Body Composition
Mortality
Health
Cardiovascular Diseases
Thigh
Smoking
Intra-Abdominal Fat
Adiposity
Proportional Hazards Models
LDL Cholesterol
HDL Cholesterol
Insulin Resistance
Weight Loss
Heart Diseases
Fasting
Triglycerides
Fats
Insulin
Hypertension

Keywords

  • Adiponectin
  • Adipose tissue
  • Body composition
  • Epidemiology
  • Mortality

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Poehls, J., Wassel, C. L., Harris, T. B., Havel, P. J., Swarbrick, M. M., Cummings, S. R., ... Kanaya, A. M. (2009). Association of adiponectin with mortality in older adults: The Health, Aging, and Body Composition Study. Diabetologia, 52(4), 591-595. https://doi.org/10.1007/s00125-009-1261-7

Association of adiponectin with mortality in older adults : The Health, Aging, and Body Composition Study. / Poehls, J.; Wassel, C. L.; Harris, T. B.; Havel, Peter J; Swarbrick, M. M.; Cummings, S. R.; Newman, A. B.; Satterfield, S.; Kanaya, A. M.

In: Diabetologia, Vol. 52, No. 4, 04.2009, p. 591-595.

Research output: Contribution to journalArticle

Poehls, J, Wassel, CL, Harris, TB, Havel, PJ, Swarbrick, MM, Cummings, SR, Newman, AB, Satterfield, S & Kanaya, AM 2009, 'Association of adiponectin with mortality in older adults: The Health, Aging, and Body Composition Study', Diabetologia, vol. 52, no. 4, pp. 591-595. https://doi.org/10.1007/s00125-009-1261-7
Poehls, J. ; Wassel, C. L. ; Harris, T. B. ; Havel, Peter J ; Swarbrick, M. M. ; Cummings, S. R. ; Newman, A. B. ; Satterfield, S. ; Kanaya, A. M. / Association of adiponectin with mortality in older adults : The Health, Aging, and Body Composition Study. In: Diabetologia. 2009 ; Vol. 52, No. 4. pp. 591-595.
@article{9ef49764945a4896880f382b9c221a06,
title = "Association of adiponectin with mortality in older adults: The Health, Aging, and Body Composition Study",
abstract = "Aims/hypothesis: Despite inverse associations with insulin resistance and adiposity, adiponectin has been associated with both increased and decreased risk of cardiovascular disease. We examined whether adiponectin is associated with total and cardiovascular mortality in older adults with well-characterised body composition. Methods: We analysed data from 3,075 well-functioning adults aged 69-79 years at baseline. Mortality data were obtained over 6.6∈±∈1.6 years. We used Cox proportional hazards models adjusting for covariates in stages to examine the association between adiponectin and total and cardiovascular mortality. Results: There were 679 deaths, 36{\%} of which were from cardiovascular disease. Unadjusted levels of adiponectin were not associated with total or cardiovascular mortality. However, after adjusting for sex and race, adiponectin was associated with an increased risk of both total mortality (hazard ratio 1.26, 95{\%} CI 1.15-1.37, per SD) and cardiovascular mortality (hazard ratio 1.35, 95{\%} CI 1.17-1.56, per SD). Further adjustment for study site, smoking, hypertension, diabetes, prevalent heart disease, HDL-cholesterol, LDL-cholesterol, renal function, fasting insulin, triacylglycerol, BMI, visceral fat, thigh intermuscular fat and thigh muscle area did not attenuate this association. This association between adiponectin and increased mortality risk did not vary by sex, race, body composition, diabetes, prevalent cardiovascular disease, smoking or weight loss. Conclusions/interpretation: Higher levels of adiponectin were associated with increased risks of total and cardiovascular mortality in this study of older persons.",
keywords = "Adiponectin, Adipose tissue, Body composition, Epidemiology, Mortality",
author = "J. Poehls and Wassel, {C. L.} and Harris, {T. B.} and Havel, {Peter J} and Swarbrick, {M. M.} and Cummings, {S. R.} and Newman, {A. B.} and S. Satterfield and Kanaya, {A. M.}",
year = "2009",
month = "4",
doi = "10.1007/s00125-009-1261-7",
language = "English (US)",
volume = "52",
pages = "591--595",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Association of adiponectin with mortality in older adults

T2 - The Health, Aging, and Body Composition Study

AU - Poehls, J.

AU - Wassel, C. L.

AU - Harris, T. B.

AU - Havel, Peter J

AU - Swarbrick, M. M.

AU - Cummings, S. R.

AU - Newman, A. B.

AU - Satterfield, S.

AU - Kanaya, A. M.

PY - 2009/4

Y1 - 2009/4

N2 - Aims/hypothesis: Despite inverse associations with insulin resistance and adiposity, adiponectin has been associated with both increased and decreased risk of cardiovascular disease. We examined whether adiponectin is associated with total and cardiovascular mortality in older adults with well-characterised body composition. Methods: We analysed data from 3,075 well-functioning adults aged 69-79 years at baseline. Mortality data were obtained over 6.6∈±∈1.6 years. We used Cox proportional hazards models adjusting for covariates in stages to examine the association between adiponectin and total and cardiovascular mortality. Results: There were 679 deaths, 36% of which were from cardiovascular disease. Unadjusted levels of adiponectin were not associated with total or cardiovascular mortality. However, after adjusting for sex and race, adiponectin was associated with an increased risk of both total mortality (hazard ratio 1.26, 95% CI 1.15-1.37, per SD) and cardiovascular mortality (hazard ratio 1.35, 95% CI 1.17-1.56, per SD). Further adjustment for study site, smoking, hypertension, diabetes, prevalent heart disease, HDL-cholesterol, LDL-cholesterol, renal function, fasting insulin, triacylglycerol, BMI, visceral fat, thigh intermuscular fat and thigh muscle area did not attenuate this association. This association between adiponectin and increased mortality risk did not vary by sex, race, body composition, diabetes, prevalent cardiovascular disease, smoking or weight loss. Conclusions/interpretation: Higher levels of adiponectin were associated with increased risks of total and cardiovascular mortality in this study of older persons.

AB - Aims/hypothesis: Despite inverse associations with insulin resistance and adiposity, adiponectin has been associated with both increased and decreased risk of cardiovascular disease. We examined whether adiponectin is associated with total and cardiovascular mortality in older adults with well-characterised body composition. Methods: We analysed data from 3,075 well-functioning adults aged 69-79 years at baseline. Mortality data were obtained over 6.6∈±∈1.6 years. We used Cox proportional hazards models adjusting for covariates in stages to examine the association between adiponectin and total and cardiovascular mortality. Results: There were 679 deaths, 36% of which were from cardiovascular disease. Unadjusted levels of adiponectin were not associated with total or cardiovascular mortality. However, after adjusting for sex and race, adiponectin was associated with an increased risk of both total mortality (hazard ratio 1.26, 95% CI 1.15-1.37, per SD) and cardiovascular mortality (hazard ratio 1.35, 95% CI 1.17-1.56, per SD). Further adjustment for study site, smoking, hypertension, diabetes, prevalent heart disease, HDL-cholesterol, LDL-cholesterol, renal function, fasting insulin, triacylglycerol, BMI, visceral fat, thigh intermuscular fat and thigh muscle area did not attenuate this association. This association between adiponectin and increased mortality risk did not vary by sex, race, body composition, diabetes, prevalent cardiovascular disease, smoking or weight loss. Conclusions/interpretation: Higher levels of adiponectin were associated with increased risks of total and cardiovascular mortality in this study of older persons.

KW - Adiponectin

KW - Adipose tissue

KW - Body composition

KW - Epidemiology

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=61449180043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449180043&partnerID=8YFLogxK

U2 - 10.1007/s00125-009-1261-7

DO - 10.1007/s00125-009-1261-7

M3 - Article

C2 - 19159917

AN - SCOPUS:61449180043

VL - 52

SP - 591

EP - 595

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 4

ER -